Principal Financial Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-580,064
| Closed | -$11.3M | – | 2345 |
|
|
2018
Q1 | $11.3M | Buy |
580,064
+13,283
| +2% | +$261K | 0.01% | 1185 |
|
|
2017
Q4 | $9.44M | Buy |
566,781
+4,149
| +0.7% | +$76K | 0.01% | 1298 |
|
|
2017
Q3 | $11.4M | Sell |
562,632
-111
| -0% | -$2.12K | 0.01% | 1157 |
|
|
2017
Q2 | $9.06M | Sell |
562,743
-14,206
| -2% | -$210K | 0.01% | 1284 |
|
|
2017
Q1 | $7.3M | Buy |
576,949
+22,713
| +4% | +$274K | 0.01% | 1379 |
|
|
2016
Q4 | $7.34M | Buy |
554,236
+4,575
| +0.8% | +$78.2K | 0.01% | 1364 |
|
|
2016
Q3 | $13M | Buy |
549,661
+51,334
| +10% | +$1.38M | 0.02% | 940 |
|
|
2016
Q2 | $14.4M | Buy |
498,327
+21,081
| +4% | +$687K | 0.02% | 811 |
|
|
2016
Q1 | $15.3M | Buy |
477,246
+28,160
| +6% | +$990K | 0.02% | 738 |
|
|
2015
Q4 | $19.2M | Buy |
449,086
+8,659
| +2% | +$346K | 0.03% | 590 |
|
|
2015
Q3 | $15.5M | Buy |
440,427
+21,862
| +5% | +$985K | 0.02% | 670 |
|
|
2015
Q2 | $19.2M | Sell |
418,565
-6,617
| -2% | -$314K | 0.03% | 595 |
|
|
2015
Q1 | $19.9M | Buy |
425,182
+10,939
| +3% | +$435K | 0.03% | 544 |
|
|
2014
Q4 | $13.1M | Buy |
414,243
+2,136
| +0.5% | +$62.5K | 0.02% | 767 |
|
|
2014
Q3 | $9.77M | Sell |
412,107
-1,050
| -0.3% | -$26.9K | 0.02% | 914 |
|
|
2014
Q2 | $12.4M | Buy |
413,157
+1,890
| +0.5% | +$51K | 0.02% | 797 |
|
|
2014
Q1 | $10.9M | Buy |
411,267
+15,346
| +4% | +$384K | 0.02% | 871 |
|
|
2013
Q4 | $9.95M | Buy |
395,921
+26,770
| +7% | +$597K | 0.02% | 894 |
|
|
2013
Q3 | $7.57M | Buy |
369,151
+5,703
| +2% | +$118K | 0.02% | 997 |
|
|
2013
Q2 | $7.25M | Buy |
+363,448
| New | +$6.45M | 0.02% | 954 |
|
Principal Financial Group's IPXL Position: Q2 2018 in Review
Principal Financial Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 580,064 shares — an estimated $11.3M sold.
Principal Financial Group first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $19.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Principal Financial Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Principal Financial Group sold 580,064 Impax Laboratories, Inc. shares in Q2 2018, an estimated $11.3M.
- Principal Financial Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Principal Financial Group's Impax Laboratories, Inc. position peaked at $19.9M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Principal Financial Group's 13F filing for Q2 2018, filed 13 Aug 2018.